A. Rizzo

Future scenarios of radioligand therapy in pheochromocytomas and paragangliomas

Pheochromocytomas and paragangliomas (PPGL) are rare and heterogeneous neuroendocrine tumors for which therapeutic options remain limited, particularly in the metastatic or progressive setting. Radioligand therapy (RLT) has emerged as a promising strategy, leveraging tumor-specific molecular targets to deliver cytotoxi...